PubMed · 2005 · 92 citations · 13 references
Open access
MedicineCancer BiologyEndocrinologyCarcinogenesisEndocrine OncologyMolecular OncologyDuctal Carcinoma In SituMalignant NeoplasmsMammary Epithelial Cell BiologyMammary Gland DevelopmentMammary TumorsSteroid Hormone SignalingBreast HyperplasiaEstrogen Receptor ExpressionEstrogen Receptor SignalingLobular Carcinoma In SituMammary Epithelial Gene RegulationTransgenic MiceTransgenic Mouse Cancer ModelsTransgenic Mouse Models
A conditional tetracycline-responsive transgenic mouse model with deregulated estrogen receptor alpha expression in mammary epithelial cells developed ductal hyperplasia (DH), lobular hyperplasia, and ductal carcinoma in situ (DCIS) by 4 months of age. Higher proliferative rates were found in both normal and abnormal ductal and lobular structures. DH and DCIS but not normal ductal structures showed an increased percentage of cells with nuclear-localized cyclin D1. No differences in either the prevalence or extent of these phenotypes following exogenous 17beta-estradiol treatment were found suggesting that alteration of ERalpha expression was the rate-limiting factor in initiation of DH, lobular hyperplasia, and DCIS.
13
Estrogen Receptor-Positive Proliferating Cells in the Normal and Precancerous Breast
Balvinder Shoker, C Jarvis, Robert B. Clarke et al. · American Journal Of Pathology · 1999 · 279 citations · Full text
Medicine, Endocrinology, Oncology +14
Linnea D. Read, Geoffrey L. Greene, Benita S. Katzenellenbogen · Molecular Endocrinology · 1989 · 261 citations · Full text